rs104894369
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_000432.4(MYL2):c.173G>T(p.Arg58Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R58Q) has been classified as Pathogenic.
Frequency
Consequence
NM_000432.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYL2 | NM_000432.4 | c.173G>T | p.Arg58Leu | missense_variant | 4/7 | ENST00000228841.15 | NP_000423.2 | |
MYL2 | NM_001406745.1 | c.131G>T | p.Arg44Leu | missense_variant | 3/6 | NP_001393674.1 | ||
MYL2 | NM_001406916.1 | c.116G>T | p.Arg39Leu | missense_variant | 4/7 | NP_001393845.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYL2 | ENST00000228841.15 | c.173G>T | p.Arg58Leu | missense_variant | 4/7 | 1 | NM_000432.4 | ENSP00000228841 | P1 | |
MYL2 | ENST00000548438.1 | c.131G>T | p.Arg44Leu | missense_variant | 3/6 | 3 | ENSP00000447154 | |||
MYL2 | ENST00000663220.1 | c.116G>T | p.Arg39Leu | missense_variant | 4/7 | ENSP00000499568 | ||||
MYL2 | ENST00000549029.1 | n.4G>T | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2023 | MYL2: PM2, PM5, PS4:Moderate - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 19, 2019 | Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Reported in ClinVar as a likely pathogenic variant (ClinVar Variant ID# 532778; Landrum et al., 2016); This variant is associated with the following publications: (PMID: 24793961, 26914223) - |
Hypertrophic cardiomyopathy 10 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 13, 2023 | This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 58 of the MYL2 protein (p.Arg58Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with hypertrophic cardiomyopathy (PMID: 26914223; Invitae). ClinVar contains an entry for this variant (Variation ID: 532778). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. This variant disrupts the p.Arg58 amino acid residue in MYL2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9535554, 12404107, 14594949, 19150977, 20855589). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at